A randomized controlled trial using the school for anti-inflammatory therapy in asthma

Area of Science:

• Pediatric Pulmonology
• Public Health
• Clinical Pharmacy

Background:

• Asthma is a prevalent chronic respiratory disease affecting inner-city children, often leading to significant morbidity.
• Current management strategies may be suboptimal, necessitating innovative delivery methods for medication.

Purpose of the Study:

• To compare the effectiveness of school-based versus home-based delivery of low-dose inhaled corticosteroids (ICS) for managing mild, persistent asthma in urban African-American children.
• To evaluate these interventions against the existing community standard of care.

Main Methods:

• A 14-week randomized controlled trial involving 50 inner-city children with mild, persistent asthma across eight elementary schools.
• Intervention groups received beclomethasone (42 mcg/puff) twice daily, either at school or home, with one group also receiving school-based asthma education.
• The control group received no changes to their current therapy.

Main Results:

• Treatment groups demonstrated higher peak flows from week 1, maintained throughout the study (P = .047).
• Significant improvements were observed by week 5 in reduced bronchodilator use (P = .025), fewer nocturnal asthma awakenings (P = .022), and decreased primary health care visits (P = .022).
• Patients receiving ICS reported their asthma status as improved more frequently than the control group (P = .001).

Conclusions:

• School-based delivery of ICS resulted in superior asthma control compared to home-based delivery.
• Both school-based and home-based ICS delivery were more effective than the community standard of care.
• Implementing ICS delivery in schools presents a promising strategy for improving asthma management in underserved pediatric populations.